CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-1,556190,10630,041
Cost of Revenue106,378160,531254,440212,680
Gross Profit-106,378-158,975-64,334-182,639
Operating Expenses
Research Development----
Selling General and Administrative94,17769,00351,59736,046
Non Recurring----
Others----
Total Operating Expenses200,555229,534306,037248,726
Operating Income or Loss-200,555-227,978-115,931-218,685
Income from Continuing Operations
Total Other Income/Expenses Net-8,854-10,308-11,857-5,253
Earnings Before Interest and Taxes-200,555-227,978-115,931-218,685
Interest Expense-9,684-9,552-7,980-33
Income Before Tax-209,409-238,286-127,788-223,938
Income Tax Expense----
Minority Interest--1,289-1,173-722
Net Income From Continuing Ops-209,409-238,286-127,788-223,938
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-209,339-238,170-127,337-223,260
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-209,339-238,170-127,337-223,260